Dr Mansukh Mandaviya addresses Global Vaccine Research Collaborative Discussion on Vaccine Research and Development, a G20 co-branded event
“The COVID-19 pandemic demonstrated the importance of global collaboration in vaccine research and development. As we navigate this once-in-a-century public health crisis, we realize the importance of research to accelerate vaccine development, particularly for emerging pathogens”
International cooperation is essential to advance vaccine development for emerging pathogens, and the G20 can serve as a vital platform to facilitate collaboration between governments, research organizations, pharmaceutical companies, and other stakeholders: Dr Mansukh Mandaviya
“The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective

Union Health and Family Welfare Minister Dr Mansukh L Mandaviya on Saturday emphasised the need for global collaborations for ensuring access to vaccines to all and the need for building capacities to face challenges in situations like pandemic like Covid 19. He addressed G20 representatives at a workshop ahead of the G20 Third Health Working Group meeting starting from tomorrow in Hyderabad. He recalled how the government took measures to increase vaccine production and carried out a massive awareness campaign about the Covid vaccine.
Telangana Industries Principal Secretary, Jayesh Ranjan informed on the occasion that Malaria vaccine will be produced in Hyderabad very soon and the vaccine has got WHO approval. He also said Hyderabad is producing one third of the global vaccine doses and the production will be increased from the current 9 billion doses to 14 billion doses by next year.